Global Organ and Tissue Transplantation Market Size study & Forecast, by Technology (Allograft, Autograft, Xenograft, And Others) by Application (Renal Failure, Liver Cirrhosis, Diabetes, Heart Failure, Lung Diseases, And Others), by Type (Kidney, Liver,

Global Organ and Tissue Transplantation Market Size study & Forecast, by Technology (Allograft, Autograft, Xenograft, And Others) by Application (Renal Failure, Liver Cirrhosis, Diabetes, Heart Failure, Lung Diseases, And Others), by Type (Kidney, Liver, Heart, Lung, Pancreas, Cornea, And Others), by Source (Deceased Donors, Living Donors, Others), by End-user (Hospitals, Transplant Centers, And Others) and Regional Analysis, 2023-2030

Global Organ and Tissue Transplantation Market is valued approximately at USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. The Global Organ and Tissue Transplantation Market refers to the market for transplantation of organs and tissues from one person (donor) to another (recipient) who has damaged or failed organs or tissues. Organ and tissue transplantation is a lifesaving procedure that has revolutionized the treatment of various chronic diseases such as kidney failure, liver cirrhosis, heart failure, lung diseases, and others. The major driving factors for the Global Organ and Tissue Transplantation Market are increasing incidences of chronic diseases and rising healthcare expenditure. Moreover, technological advancement and favorable reimbursement policies are creating lucrative growth opportunities for the market over the forecast period 2022-2029.

There have been several favorable reimbursement policies for organ and tissue transplantation procedures across the world. For instance, in the United States, Medicare covers organ and tissue transplantation procedures for eligible patients. Additionally, several private insurance companies offer coverage for these procedures. Similarly, in Australia, the National Health and Medical Research Council provides funding for organ and tissue transplantation research, and Medicare covers the costs of transplantation procedures for eligible patients. Additionally, in Canada, provincial healthcare plans cover the costs of organ and tissue transplantation procedures for eligible patients. However, the high cost of Organ and Tissue Transplantation stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Organ and Tissue Transplantation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America organ and tissue transplantation market is the dominating in term of revenueglobally due to the presence of advanced healthcare infrastructure, high awareness about transplantation, and favorable reimbursement policies. The US accounts for the majority of the market share in this region. The Asia Pacific market for organ and tissue transplantation is expected to witness fastest growth due to the increasing incidence of chronic diseases, rising healthcare expenditure, and growing awareness about transplantation. China, India, and Japan are the major contributors to the market in this region.

Major market player included in this report are:
AbbVie Inc.
Astellas Pharma Inc.
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd
Novartis AG
Pfizer Inc.
Sanofi S.A.
Terumo Corporation
Zimmer Biomet Holdings, Inc.

Recent Developments in the Market:
In 2021, Medtronic announced the launch of a new cell processing platform called the Carpediem System, which is designed to improve the quality and availability of kidneys for transplantation. The system is expected to increase the number of kidneys available for transplant by up to 30%.
OrganOx is a UK-based company that has developed a new technology for preserving and transporting organs for transplantation. In 2020, the company received approval from the US Food and Drug Administration (FDA) for its liver preservation system, which allows for the transportation of livers over longer distances and increases the number of organs available for transplantation.

Global Organ and Tissue Transplantation Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Technology, Application, Type, Source, End-users, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
 Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Technology:
Allograft
Autograft
Xenograft
Others
By Application:
Renal Failure
Liver Cirrhosis
Diabetes
Heart Failure
Lung Diseases
Others
By Type:
Kidney
Liver
Heart
Lung
Pancreas
Cornea
Others
By Source:
Deceased Donors
Living Donors
Others
By End-user:
Hospitals
Transplant Centers
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned

AbbVie Inc.
Astellas Pharma Inc.
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd
Novartis AG
Pfizer Inc.
Sanofi S.A.
Terumo Corporation
Zimmer Biomet Holdings, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.